Back to Search Start Over

Oxidative Stress: A Potential Therapeutic Target in Placental Malaria.

Authors :
Sarr D
Cooper CA
Bracken TC
Martinez-Uribe O
Nagy T
Moore JM
Source :
ImmunoHorizons [Immunohorizons] 2017 Jun 01; Vol. 1 (4), pp. 29-41.
Publication Year :
2017

Abstract

Placental malaria, characterized by sequestration of Plasmodium falciparum in the maternal placental blood space and associated inflammatory damage, contributes to poor birth outcomes and ~200,000 infant deaths annually. Specific mechanisms that contribute to placental damage and dysfunction during malaria are not completely understood. To investigate a potential role for oxidative stress, antioxidant genes and markers for oxidative damage were assessed by quantitative PCR and immunohistochemistry in Plasmodium chabaudi AS-infected pregnant mice. Widespread evidence of lipid peroxidation was observed and was associated with higher antioxidant gene expression in conceptuses of infected mice. To assess the extent to which this oxidative damage might contribute to poor birth outcomes and be amenable to therapeutic intervention, infected pregnant mice were treated with N -acetylcysteine, a free radical scavenger, or tempol, an intracellular superoxide dismutase mimetic. The results show that mice treated with N -acetylcysteine experienced malaria induced-pregnancy loss at the same rate as control animals and failed to mitigate placental oxidative damage. In contrast, tempol-treated mice exhibited subtle improvement in embryo survival at gestation day 12. Although lipid peroxidation was not consistently reduced in the placentas of these mice, it was inversely related to embryo viability. Moreover, reduced IFN-γ and CCL2 plasma levels in treated mice were associated with midgestational embryo viability. Thus, although oxidative stress is remarkable in placental malaria and its mitigation by antioxidant therapy may improve pregnancy outcomes, the underlying mechanistic basis and potential therapeutic strategies require additional investigation.<br />Competing Interests: DISCLOSURES The authors have no financial conflicts of interest.

Details

Language :
English
ISSN :
2573-7732
Volume :
1
Issue :
4
Database :
MEDLINE
Journal :
ImmunoHorizons
Publication Type :
Academic Journal
Accession number :
28890952
Full Text :
https://doi.org/10.4049/immunohorizons.1700002